Ipamorelin vs Testosterone for weight loss
Short answer: For weight loss, users rate them about the same: 93% report improvement with Ipamorelin (43 reports) and 93% with Testosterone (45 reports).
Ipamorelin has 0 meta-analyses and 2 randomized trials on PubMed; Testosterone has 75 and 125.
Based on 378 reports about Ipamorelin and 822 about Testosterone. Not medical advice.
| Ipamorelin Peptide | Testosterone Medication | |
|---|---|---|
| User score | 18 | 54 |
| Verdict | Mostly positive | Mostly positive |
| Positive of reports that state an outcome | 63% | 77% |
| Reports | 378 | 822 |
| Research | CResearch: Limited | AResearch: Strong |
| Meta-analyses / RCTs | 0 / 2 | 75 / 125 |
| Mainly used for | ||
| Weight loss % reporting improvement | 93% (43) | 93% (45) |
| Appetite % reporting improvement | 25% (12) | — |
| Focus % reporting improvement | 100% (5) | 82% (28) |
| Energy % reporting improvement | 88% (17) | 92% (76) |
| Sleep % reporting improvement | 77% (65) | 79% (19) |
| Anxiety % reporting improvement | — | 80% (25) |
| Mood % reporting improvement | 100% (8) | 88% (104) |
| Memory % reporting improvement | — | 100% (2) |
| Performance % reporting improvement | 82% (33) | 97% (149) |
| Recovery % reporting improvement | 88% (43) | 91% (23) |
| Pain & inflammation % reporting improvement | 100% (13) | 67% (6) |
| Digestion % reporting improvement | 33% (3) | — |
| Libido % reporting improvement | — | 93% (70) |
| Hormones % reporting improvement | 72% (18) | 90% (91) |
| Blood sugar % reporting improvement | 0% (3) | — |
| Heart & lipids % reporting improvement | — | 62% (8) |
| Skin & hair % reporting improvement | 91% (11) | 40% (5) |
| Longevity % reporting improvement | — | 50% (2) |
| Common side effects | insomnia, flushing, water retention, fatigue | suppression, hair loss, acne, water retention |
| Typical dose reported | Not listed | 200 mg / weekly |
IpamorelinFull Ipamorelin profile →
What a user said
“CJC-1295, Ipamorelin, rHGH all help. Helped me recover from Phenibut overuse and dependence, and heavy stimulants.”
TestosteroneFull Testosterone profile →
Latest review conclusion
The guidelines also provide recommendations regarding identification of patients, dosing, monitoring, and follow-up. This Practice Pearl will discuss evidence-based testosterone therapy for management of HSDD in postmenopausal women.
Menopause, 2023 ↗What a user said
“Feel the best I've ever felt in my life. TRT and peptides have been game changers for me!”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate